These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6180101)

  • 1. Interim report on studies on "toxic" effects of human leucocyte-derived interferon-alpha (HuIFN-alpha).
    Scott GM; Wallace J; Tyrrell DA; Cantell K; Secher DS; Stewart WE
    J Interferon Res; 1982; 2(1):127-30. PubMed ID: 6180101
    [No Abstract]   [Full Text] [Related]  

  • 2. Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.
    Braude IA; Lin LS; Stewart WE
    Biochem J; 1981 Mar; 193(3):947-51. PubMed ID: 6171256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparison of leukocyte and Escherichia coli-derived human interferon type alpha.
    Sarkar FH
    Antiviral Res; 1982 May; 2(1-2):103-6. PubMed ID: 6179467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatography of human leukocyte interferon on controlled pore glass.
    Chadha KC; Sulkowski E
    Prep Biochem; 1981; 11(4):467-82. PubMed ID: 6171806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of interferon.
    Scott GM; Secher DS; Flowers D; Bate J; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1345-8. PubMed ID: 6165428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of human interferon-beta in monkeys.
    Hilfenhaus J; Damm H; Hofstaetter T; Mauler R; Ronneberger H; Weinmann E
    J Interferon Res; 1981; 1(3):427-36. PubMed ID: 6180075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of interferon on the inhibition of malignant cell growth by human peripheral leukocytes. III. Effect of systemic administration].
    Kita M; Imanishi J; Kishida T
    C R Seances Soc Biol Fil; 1981; 175(6):904-9. PubMed ID: 6173108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 12. Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro.
    Billard C; Ferbus D; Kolb JP; Rosa F; Perrot JY; Merlin G; Janiaud P; Raynaud N; Thang MN; Fellous M
    Ann Inst Pasteur Immunol (1985); 1986; 137C(3):259-72. PubMed ID: 3090926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus.
    Greenberg SB; Harmon MW; Couch RB; Johnson PE; Wilson SZ; Dacso CC; Bloom K; Quarles J
    J Infect Dis; 1982 Apr; 145(4):542-6. PubMed ID: 6175705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.
    Merigan TC; Sikora K; Breeden JH; Levy R; Rosenberg SA
    N Engl J Med; 1978 Dec; 299(26):1449-53. PubMed ID: 362211
    [No Abstract]   [Full Text] [Related]  

  • 15. Copper chelate affinity chromatography of human fibroblast and leucocyte interferons.
    Chadha KC; Grob PM; Mikulski AJ; Davis LR; Sulkowski E
    J Gen Virol; 1979 Jun; 43(3):701-6. PubMed ID: 479851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preventive effect of human interferon-alpha preparation on upper respiratory disease.
    Imanishi J; Karaki T; Sasaki O; Matsuo A; Oishi K; Pak CB; Kishida T; Toda S; Nagata H
    J Interferon Res; 1980; 1(1):169-78. PubMed ID: 6180040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity studies with human leukocyte interferon in newborn rabbits.
    Pyhälä L; Rimaila-Pärnänen E; Kekomäki R; Kostiainen E; Cantell K
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):45-51. PubMed ID: 696330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon production in multiple sclerosis].
    Khaletskaia EV; Fadeeva LL; Selezneva AIu; Priĭmiagi LS; Luka VIa
    Vopr Virusol; 1981; (2):218-21. PubMed ID: 6168116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic cross-reaction between the alpha types of human and mouse interferon.
    Kawade Y; Watanabe Y; Yamamoto Y; Fujisawa J; Dalton BJ; Paucker K
    Antiviral Res; 1981 Sep; 1(3):167-78. PubMed ID: 6175276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of human cells trisomic for chromosome 21 to the antiviral action of human immune interferon.
    De Ley M; Billiau A
    Antiviral Res; 1982 May; 2(1-2):97-102. PubMed ID: 6179471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.